Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Editorial updates to the Publications section add a note that publications are automatically filled from PubMed and update the page revision label to v3.3.2, replacing the previous PubMed wording and the earlier revision label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:23:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the general operating status notice about government funding and NIH Clinical Center operations. The trial details, eligibility criteria, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T19:14:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The new screenshot shows only minor formatting and wording changes with no modifications to the study content or user-facing functions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:43.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential data and processing delays due to funding lapse and updated operating status guidance, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T01:57:23.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated revision to v3.1.0 with new contact details (phone numbers and email) and removal of the previous revision tag (v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-28T23:23:09.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The only other visible change is removal of 'Back to Top'; no substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T09:54:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.